These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 38164933)

  • 21. Monkeypox-Related Stigma and Vaccine Challenges as a Barrier to HIV Pre-Exposure Prophylaxis among Black Sexual Minority Men.
    Turpin RE; Mandell CJ; Camp AD; Davidson Mhonde RR; Dyer TV; Mayer KH; Liu H; Coates T; Boekeloo BO
    Int J Environ Res Public Health; 2023 Jul; 20(14):. PubMed ID: 37510557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV and Sexually Transmitted Infections Among Persons with Monkeypox - Eight U.S. Jurisdictions, May 17-July 22, 2022.
    Curran KG; Eberly K; Russell OO; Snyder RE; Phillips EK; Tang EC; Peters PJ; Sanchez MA; Hsu L; Cohen SE; Sey EK; Yin S; Foo C; Still W; Mangla A; Saafir-Callaway B; Barrineau-Vejjajiva L; Meza C; Burkhardt E; Smith ME; Murphy PA; Kelly NK; Spencer H; Tabidze I; Pacilli M; Swain CA; Bogucki K; DelBarba C; Rajulu DT; Dailey A; Ricaldi J; Mena LA; Daskalakis D; Bachmann LH; Brooks JT; Oster AM;
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(36):1141-1147. PubMed ID: 36074735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis.
    Songtaweesin WN; Pornpaisalsakul K; Kawichai S; Wacharachaisurapol N; Wongharn P; Yodkitudomying C; Panichnantakul P; Theerawit T; Pankam T; Puthanakit T
    Int J STD AIDS; 2022 Apr; 33(5):447-455. PubMed ID: 35282719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homophobia in the provision of sexual health care in the UK.
    Kohli M; Reeves I; Waters L
    Lancet HIV; 2024 Feb; 11(2):e125-e130. PubMed ID: 38218200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Pre-exposure Prophylaxis for Human Immunodeficiency Virus on Gonorrhea Prevalence.
    Pharaon J; Bauch CT
    Bull Math Biol; 2020 Jul; 82(7):85. PubMed ID: 32613297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gaps in Sexually Transmitted Infection Screening Among Men who Have Sex with Men in Pre-exposure Prophylaxis (PrEP) Care in the United States.
    Chandra C; Weiss KM; Kelley CF; Marcus JL; Jenness SM
    Clin Infect Dis; 2021 Oct; 73(7):e2261-e2269. PubMed ID: 32702116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-exposure prophylaxis and bacterial sexually transmitted infections (STIs) among gay and bisexual men.
    Hart TA; Noor SW; Berlin GW; Skakoon-Sparling S; Tavangar F; Tan D; Lambert G; Grace D; Lachowsky NJ; Jollimore J; Sang J; Parlette A; Lal A; Apelian H; Moore D; Cox J;
    Sex Transm Infect; 2023 May; 99(3):167-172. PubMed ID: 35701145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility and impact of online HIV/STI screening addressed to men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) in Spain (TESTATE PrEP): a study protocol for a non-blinded randomised controlled trial.
    Agustí C; Martínez Riveros H; García-Pérez J; Descalzo V; Fernandez G; Ramírez-Marinero A; Gonzalez MV; Díaz Y; Montoro-Fernandez M; Romano-deGea P; Araujo SG; Muntada E; Casabona J
    BMJ Open; 2023 Oct; 13(10):e073459. PubMed ID: 37844988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying heterogeneity in sexual behaviour and distribution of STIs before and after pre-exposure prophylaxis among men who have sex with men.
    van Wees DA; Diexer S; Rozhnova G; Matser A; den Daas C; Heijne J; Kretzschmar M
    Sex Transm Infect; 2022 Sep; 98(6):395-400. PubMed ID: 34716228
    [No Abstract]   [Full Text] [Related]  

  • 31. Study Evaluating Self-Collected Specimen Return for HIV, Bacterial STI, and Potential Pre-Exposure Prophylaxis Adherence Testing Among Sexual Minority Men in the United States.
    Sharma A; Gandhi M; Sallabank G; Merrill L; Stephenson R
    Am J Mens Health; 2022; 16(4):15579883221115591. PubMed ID: 35950608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.
    Marcus U; Schink SB; Weber C
    BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment for sexually transmitted infections in men who have sex with men attending a nurse-run HIV preexposure prophylaxis clinic.
    Stockton JM
    J Am Assoc Nurse Pract; 2021 Feb; 33(12):1290-1294. PubMed ID: 33625163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated With Willingness to Use Daily Antibiotics as Sexually Transmitted Infection Prophylaxis Among HIV Preexposure Prophylaxis-Experienced Gay and Bisexual Men in Australia.
    Arapali T; Grulich AE; Heywood AE; Chan C; Fraser D; Zablotska IB; Holt M; Vaccher SJ; Bavinton BR
    Sex Transm Dis; 2023 Mar; 50(3):144-149. PubMed ID: 36730780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV risk profile and prevention needs of individuals seeking monkeypox (mpox) vaccination in an urban clinic in the U.S.: a brief report.
    Ogbuagu O; Sharma M; Igiraneza G; Andrews L; Tuan J; Barakat LA
    BMC Infect Dis; 2023 Mar; 23(1):146. PubMed ID: 36890468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections.
    Pagkas-Bather J; Khosropour CM; Golden MR; Thibault C; Dombrowski JC
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):769-775. PubMed ID: 33538527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort.
    Nozza S; Raccagni AR; Lolatto R; Ceccarelli D; Galli L; Alberton F; Bruzzesi E; Canetti D; Strano M; Ripa M; Bertoni C; Castagna A
    BMJ Open; 2022 Dec; 12(12):e067261. PubMed ID: 36600429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Smartphone Text Data Related to mpox from a U.S. Sample of Gay, Bisexual, and Other Men Who Have Sex with Men During the 2022 Outbreak.
    Cascalheira CJ; Hong C; Beltran RM; Karkkainen K; Beikzadeh M; Sarrafzadeh M; Holloway IW
    LGBT Health; 2023 Oct; 10(7):560-565. PubMed ID: 37219872
    [No Abstract]   [Full Text] [Related]  

  • 39. Perceptions and Experiences of Returning Self-collected Specimens for HIV, Bacterial STI and Potential PrEP Adherence Testing among Sexual Minority Men in the United States.
    Sharma A; Gandhi M; Sallabank G; Merrill L; Stephenson R
    AIDS Behav; 2023 Apr; 27(4):1091-1105. PubMed ID: 36094639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Club drug users had higher odds of reporting a bacterial STI compared with non-club drug users: results from a cross-sectional analysis of gay and bisexual men on HIV pre-exposure prophylaxis.
    John SA; Parsons JT; Rendina HJ; Grov C
    Sex Transm Infect; 2019 Dec; 95(8):626-628. PubMed ID: 30126949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.